Avidicure
Seed Round in 2025
Avidicure is a cancer care company focused on enhancing immune system performance through innovative therapeutic approaches. The company is developing a novel class of antibodies known as AVC-Boosters, which are engineered to act as dual agonists. This multifunctional modality aims to deliver targeted and effective monotherapy, offering broad applicability in oncology. Currently operating in stealth mode, Avidicure is dedicated to pioneering advancements in cancer treatment that prioritize safety and efficacy.
EAGLE RAILCAR SERVICES
Acquisition in 2025
EAGLE RAILCAR SERVICES is one of the nation's leading independent providers of railcar repair services.
ReliaQuest
Private Equity Round in 2025
ReliaQuest is a cybersecurity company based in Tampa, Florida, founded in 2007. It specializes in providing a cloud-native security platform called GreyMatter, which offers a comprehensive solution for minimizing data loss and business disruptions. The platform enhances visibility across Security Information and Event Management (SIEM), Endpoint Detection and Response (EDR), and multi-cloud environments, facilitating faster detection and response to security threats. By automating processes throughout the security lifecycle, ReliaQuest enables organizations to manage their security investments effectively and make informed decisions regarding their cybersecurity posture. The company's offerings are designed to protect enterprise environments from security breaches while ensuring compliance and enhancing overall security confidence.
Perfuze
Venture Round in 2025
Perfuze is a neurovascular medical device company based in Galway, Ireland, founded in 2018. The company focuses on developing innovative catheter technology specifically for the treatment of acute ischemic stroke. Perfuze aims to enhance clinical outcomes and reduce procedural times through its proprietary catheter-based aspiration technology, which optimizes the efficiency of clot removal. By simplifying procedures and minimizing the need for alternative treatment methods, Perfuze seeks to provide cost-effective solutions for patients suffering from ischemic stroke.
TravelPerk
Series E in 2025
TravelPerk is a comprehensive platform designed to streamline business travel management by consolidating booking, reporting, and support into a single solution. The platform offers a diverse selection of travel options, including flights, hotels, and car rentals, which allows users to book their travel easily while adhering to company policies. It features an automated system that integrates customer service, reporting tools, and expense management capabilities, enabling organizations to oversee their travel arrangements effectively. Additionally, TravelPerk's technology facilitates the enforcement of travel policies, cost control, and data analysis, ultimately simplifying the travel planning process for businesses and their employees.
Cornerstone Robotics
Series C in 2025
Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.
Scale Microgrid Solutions
Acquisition in 2025
Scale Microgrid Solutions, Inc. is a company that designs, builds, operates, and finances on-site power systems for commercial and industrial facilities across North America. Founded in 2016 and based in Ridgewood, New Jersey, the company specializes in multi-resource clean energy microgrids that support both daily operations and power outage scenarios. Its innovative offerings include the rapid response modular microgrid system, which optimizes solar photovoltaic energy, battery storage, and dispatchable generation. By providing fully-financed microgrid solutions, Scale Microgrid Solutions aims to deliver sustainable, reliable power while simplifying the microgrid development process for its customers.
XyloCor Therapeutics
Series B in 2025
XyloCor Therapeutics, Inc. is a biopharmaceutical company specializing in the development of gene therapies for cardiovascular diseases, particularly advanced coronary artery disease. Founded in 2013 and based in Newtown Square, Pennsylvania, the company focuses on innovative treatments aimed at addressing significant unmet medical needs. Its lead product candidate, XC001, is currently in clinical development for patients suffering from refractory angina, targeting individuals who have exhausted other treatment options. XyloCor's approach centers on stimulating the formation of new coronary blood vessels to enhance blood supply to areas of the heart that are inadequately perfused, thereby improving patient outcomes in those affected by heart failure and ischemic conditions. The company collaborates with Weill Cornell Medical College to advance its gene therapy technologies.
Tenpoint Therapeutics
Venture Round in 2024
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Noema Pharma
Series B in 2024
Noema Pharma AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company focuses on developing innovative therapeutic products for orphan neurological disorders characterized by imbalanced neuronal networks. Its research and development efforts are dedicated to addressing disabling symptoms associated with conditions affecting the nervous system, such as Tuberous Sclerosis Complex, Trigeminal Neuralgia, and Tourette syndrome. By creating novel therapies, Noema Pharma aims to enhance the quality of life and improve patient outcomes for those suffering from these challenging disorders.
NUA Surgical
Series A in 2024
NUA Surgical is an award-winning startup based at the Innovation Hub in Galway, Ireland. The company has developed a patented surgical retractor designed to enhance the safety and efficiency of C-section procedures. NUA Surgical focuses on creating innovative medical devices for women's health, with a particular emphasis on improving outcomes for cesarean deliveries.
Ju:niz Energy
Acquisition in 2024
Ju:niz Energy, based in Aschheim, Germany, specializes in developing sustainable real estate and renewable energy solutions. The company constructs eco-friendly residential and commercial properties, complemented by large-scale energy storage systems and local energy centers, all adhering to technical standards.
Calisen
Acquisition in 2024
Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two primary business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring, owning, and managing a portfolio of electricity and gas meters, primarily smart meters, for energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, maintenance services, and ancillary support, such as customer service and call center operations, also on behalf of energy retailers. Calisen aims to capitalize on the UK government's initiative to roll out smart meters and is committed to supporting a cleaner and more sustainable energy sector by offering innovative services, including electric vehicle charging solutions. The company was incorporated in 2020.
ATB Therapeutics
Series A in 2024
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
PageUp
Acquisition in 2024
PageUp People Limited is a provider of a cloud-based talent management platform designed to assist organizations in effectively managing various human resource functions. Founded in 1980 and headquartered in Melbourne, Australia, the company offers a comprehensive suite of services that includes recruitment, onboarding, performance management, learning and development, succession planning, and analytics. Its platform enables clients to streamline their talent management processes, providing tools for hiring, employee training, and career tracking. PageUp serves a diverse range of clients, including major organizations such as AEGIS, AngloAmerican, and National Australia Bank, and has established additional offices in Sydney, Singapore, Hong Kong, New York, and London.
Neara provides predictive modeling software designed to help utility companies manage their networks proactively. Their cloud-based enterprise platform is tailored for the electric and power infrastructure industry. It uses advanced algorithms to create a three-dimensional, physics-enabled model of energy utilities, enhancing visualization and reporting. This allows users to simulate severe weather scenarios, assess network vulnerabilities, and make informed decisions to optimize asset management across the entire network.
Vinted
Secondary Market in 2024
Vinted is an online marketplace that focuses on promoting second-hand fashion as a preferred choice for consumers. The platform allows users, primarily targeting girls and women, to buy, sell, and swap clothing, accessories, and lifestyle items in a peer-to-peer environment. Vinted enhances the shopping experience by incorporating an online chatting feature, facilitating communication between users and making transactions simpler and more efficient. With a mobile-first approach, Vinted aims to make second-hand shopping accessible and cost-effective for its community.
OX2 is a company focused on providing renewable energy solutions, including the development and sale of wind and solar farms. They operate in several countries across Europe, such as Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania. In addition to their core activities in solar and onshore and offshore wind farms, OX2 is also involved in energy storage projects and the development of hydrogen solutions. The company emphasizes technical and business management solutions to support its various energy initiatives.
Sequana Medical
Post in 2024
Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.
Indostar Home Finance
Acquisition in 2024
Indostar Home Finance is a housing finance company that provides mortgages to retail clients in tier 2 to tier 4 cities and has supported low-income homeowners and small companies.
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
GeBBS Healthcare Solutions
Acquisition in 2024
GeBBS Healthcare Solutions is a technology-enabled company that provides revenue cycle management (RCM) solutions to improve financial performance, compliance, and patient satisfaction. Founded in 2005 and headquartered in Culver City, California, GeBBS offers a range of services including Health Information Management (HIM), Revenue Cycle Management (RCM), Patient Access, Risk Adjustment Solutions, strategic outsourcing, and consulting services. The company serves hospitals, physician groups, health plans, and medical billing companies. With over 6,000 employees globally, GeBBS has formed strategic partnerships with various industry associations and organizations.
Compass Education
Private Equity Round in 2024
Compass Education is a provider of a cloud-based school management platform designed to enhance operational efficiency for educational institutions. Serving customers primarily in Victoria, New South Wales, Brisbane, and Dublin, the platform features a multilingual and multi-currency student information system. It offers a comprehensive suite of modules that address critical areas such as attendance tracking, reporting, parent communication, student well-being, learning management, staff development, online payments, event management, and data analytics. By streamlining these processes, Compass Education enables schools to reduce administrative burdens, allowing administrators to focus on engaging with the school community and delivering high-quality learning experiences.
PropertyGuru
Acquisition in 2024
PropertyGuru Limited is a property technology company based in Singapore, operating online property classifieds marketplaces across Singapore, Vietnam, Malaysia, Thailand, and Indonesia. Established in 2006, it serves as a vital platform for agents and developers to advertise residential and commercial properties for sale or rent, connecting them with property seekers. The company features a flagship website, PropertyGuru.com.sg, which attracts over 4.5 million consumers who engage with more than 50 million pages. In addition to its marketplace services, PropertyGuru offers digital marketing solutions for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, as well as property data consultancy services aimed at banks, valuers, and property developers. Its operations are segmented into distinct geographic markets and include fintech and data services, solidifying its position as a key player in the property technology sector in Southeast Asia.
KJ Environment
Acquisition in 2024
KJ Environment is an environmental and energy infrastructure specialist is establishing a scaled and diverse end-to-end waste treatment platform focusing on plastic recycling and waste-to-electricity conversion.
AMCS Group
Acquisition in 2024
AMCS Group is an Irish company headquartered in Limerick, specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Founded in 2002 by James Martin and Austin Ryan, AMCS offers a comprehensive range of products, including RFID technology, weighing systems, and ERP software, which facilitate efficient management of operations such as bin, vehicle, and skip management. The company’s platform is designed to standardize and optimize business processes, enabling clients to reduce operating costs, enhance asset utilization, and improve customer service. AMCS Group serves a diverse clientele, including municipalities, private recycling firms, and commercial waste haulers, helping them transition towards a circular economy for better resource management and logistics.
Acronis
Acquisition in 2024
Acronis, Inc. is a global provider of backup software, disaster recovery, and secure data access solutions, catering to consumers, small to medium-sized businesses, and enterprises. Established in 2000 and headquartered in Woburn, Massachusetts, Acronis offers a comprehensive range of services, including physical, virtual, and cloud server backup solutions, as well as storage management and secure file sharing. The company's innovative Acronis AnyData engine delivers protection across various devices and environments, while its Acronis Cyber Protect solution integrates data protection with cybersecurity to address safety, accessibility, privacy, authenticity, and security challenges. Acronis employs advanced technologies, including AI-driven anti-malware and blockchain-based data authentication, to safeguard data in cloud, hybrid, and on-premises settings. With a workforce of over 2,000 employees and a presence in 45 locations, Acronis serves a diverse clientele across sectors such as public services, healthcare, and publishing, supporting more than 750,000 businesses worldwide.
Asceneuron
Series C in 2024
Asceneuron SA, established in 2012 and headquartered in Lausanne, Switzerland, is a biotechnology subsidiary of Merck KGaA dedicated to discovering and developing therapeutics for neurodegenerative disorders with high unmet medical needs. The company focuses on progressive supranuclear palsy, orphan tauopathies, Alzheimer's disease, and Parkinson's disease, aiming to provide effective treatments where none currently exist or are limited in their benefits. Asceneuron operates by targeting the underlying causes of these debilitating conditions, such as abnormal tau protein deposits, with the goal of developing orally bioavailable therapeutics that can improve patients' lives and address the growing healthcare burden posed by neurodegenerative diseases.
FlixBus
Private Equity Round in 2024
FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.
Peak3 is a developer of insurtech software that delivers technical solutions and professional services to businesses. The company focuses on providing digital insurance options that are affordable and easily accessible, catering to the increasing demands of on-demand customers. By leveraging digital ecosystems, Peak3 enables users to redefine the insurance landscape and seamlessly integrate relevant protection into their customer journeys. Through its innovative platform, Peak3 aims to simplify the insurance process and enhance the overall experience for users.
Perficient
Acquisition in 2024
Perficient is an information technology consulting firm that specializes in software development and digital consultancy services. The company assists clients in leveraging Internet-based technologies to enhance productivity and competitiveness, while also strengthening relationships with customers, suppliers, and partners. Perficient offers a comprehensive range of services, including big data analytics, technology platform implementations, enterprise content management, portals and collaboration, management consulting, custom applications, business integration, business process management, and customer relationship management. It primarily serves clients in the healthcare, financial services, retail, and electronics industries, with most of its revenue generated in the United States.
WSO2 Inc. is a developer of an open-source enterprise middleware platform that facilitates digital transformation for organizations worldwide. Founded in 2005 and headquartered in Mountain View, California, with additional offices across various countries, WSO2 provides tools for enterprise architects to build, integrate, manage, secure, and analyze APIs, applications, and microservices across diverse environments, including on-premises and cloud settings. The company's offerings include WSO2 Developer Studio, WSO2 Private PaaS, and WSO2 App Cloud, which support application development and hosting, as well as customer identity and access management solutions. WSO2's API-first approach enables organizations to efficiently harness their APIs, enhancing user experiences while managing over 1 billion identities and executing trillions of transactions annually. The company serves multiple sectors, including healthcare, finance, retail, and technology, positioning itself as a significant player in the digital landscape.
Universidad Europea
Acquisition in 2024
Universidad Europea is an innovative higher education institution focused on enhancing societal value and progress. It operates a network of schools and educational facilities that offer a range of undergraduate and graduate programs designed to meet the demands of today’s job market. By providing an international and tailored educational experience, Universidad Europea aims to equip students with the skills and knowledge necessary for personal and professional success. The institution is dedicated to building the future of higher education through its commitment to quality and relevance in its academic offerings.
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.
Avetta
Acquisition in 2024
Avetta, LLC is a software company specializing in supply chain risk management through its SaaS platform designed for managing suppliers, contractors, and vendors. The company offers a suite of solutions, including PICS Organizer for collecting and analyzing contractor information, DocuGUARD for verifying contractor forms, and InsureGUARD for reviewing insurance certificates. Additionally, Avetta provides AuditGUARD for various auditing solutions and EmployeeGUARD for assessments at the employee level. The Enterprise Organizer enhances communication and contractor management, while GUARDBuilder allows customization of contractor information tracking. Serving a diverse range of industries such as oil and gas, pharmaceuticals, and construction, Avetta connects organizations with qualified suppliers to promote safety and sustainability. Founded in 2003 and based in Orem, Utah, Avetta operates additional offices worldwide, reflecting its commitment to global service and innovation in contractor management. The company was formerly known as PICS Auditing, LLC until its rebranding in 2016.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
Phagenesis
Series D in 2024
Phagenesis Limited is a medical device company based in Manchester, United Kingdom, founded in 2007. It focuses on developing innovative technology to treat dysphagia, a condition often associated with stroke and brain injuries that impairs safe swallowing. The company's flagship product, Phagenyx, consists of a base station that delivers targeted electrical stimulations to patients while recording and storing their information, and a catheter that is introduced through the nose to stimulate the pharynx. This approach leverages the brain’s neuroplasticity, enabling patients to relearn essential swallowing functions that may have been lost due to brain damage. Phagenesis aims to improve the recovery process for stroke patients in acute care settings by utilizing a method developed by Prof. Shaheen Hamdy of the University of Manchester, which has been validated through publication in reputable scientific and medical journals.
Believe is a digital distributor focused on independent music, dedicated to supporting local artists and labels throughout their digital journeys. The company operates primarily through two segments: Premium Solutions and Automated Solutions. Premium Solutions involves the sale, promotion, and delivery of digital content for artists and labels, where Believe develops their catalogs across various digital platforms and social media, utilizing a revenue-sharing model. In contrast, Automated Solutions allows artists to distribute their audio content through the TuneCore platform, enabling a more streamlined and automated approach to reaching streaming services and social media. By prioritizing justice, expertise, respect, and transparency, Believe aims to empower independent musicians and enhance their visibility in the digital landscape.
Onera Health
Series C in 2024
Onera Health, Inc. specializes in sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, the company utilizes advanced sleep diagnostic patch systems that collect and analyze sleep data. These innovative solutions are designed to enhance patient care by providing comprehensive sleep test data to healthcare professionals across various settings, thereby improving the management of sleep-related ailments and potentially benefiting other medical fields through remote monitoring of chronic conditions. Onera Health's mission is to improve the health and quality of life for individuals struggling with sleep issues while also contributing to cost reductions in healthcare.
InstaVolt
Private Equity Round in 2024
InstaVolt Ltd is a UK-based company that specializes in the development, construction, ownership, and operation of electric vehicle (EV) charging stations. Incorporated in 2016 and headquartered in Basingstoke, InstaVolt is committed to enhancing the accessibility and convenience of EV charging across the country. The company installs and maintains rapid charging units at various locations, including retail and food service sites, allowing landowners to generate rental income while providing EV drivers with efficient charging options. InstaVolt operates on an open charger model, enabling users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards. With a focus on improving air quality and reducing carbon emissions, InstaVolt aims to alleviate range anxiety, a significant barrier to EV adoption, by ensuring that rapid charging points are readily available throughout the UK.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.
Indium Software
Acquisition in 2023
Indium Software is a rapidly expanding digital engineering services company that specializes in delivering innovative solutions in applications and data. The firm leverages advanced technologies, including Generative AI and data analytics, to offer a wide array of services such as Low-Code Development, Data Engineering, AI/ML, and Quality Engineering. Indium's expertise extends to various domains, including application engineering, cloud engineering, DevOps, digital assurance, and gaming. By focusing on these next-generation offerings, Indium aims to help clients effectively harness technology to achieve measurable business outcomes.
HVD Group
Private Equity Round in 2023
HVD Group offers cloud-based end-to-end field service management and enterprise resource planning software with key functionalities such as order, project and asset management, scheduling, time reporting, procurement and documentation handling.
Next One Technology
Private Equity Round in 2023
Next One Technology operates within the cloud management and information technology sectors, focusing on the construction, contracting, and service industries. The company develops cloud-based systems, including Next Project and Next Field, which are designed to streamline project administration and enhance control over financial and payroll processes for businesses of all sizes. By providing user-friendly tools and environments, Next One Technology aims to improve efficiency, facilitate growth, and increase profitability for its clients. Additionally, the company is dedicated to making technology education accessible, offering resources that enable individuals to learn tech skills and upskill software teams, thus simplifying developer workflows.
Zeus Industrial Products
Acquisition in 2023
Zeus Industrial Products is a manufacturer specializing in polymer extrusion and material science innovation. The company provides a diverse range of products, including fluoropolymers, custom extruded items, and specialized heavy construction products. Additionally, Zeus offers heavy wall and convoluted products, as well as PTFE and FEP heat shrink products. Their expertise in these areas positions them as a key player in the polymer industry, catering to various industrial needs.
LUMA Vision
Series A in 2023
LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. Utilizing advanced four-dimensional imaging and artificial intelligence, LUMA Vision improves the efficacy of electrophysiology (EP) and structural heart interventions. The company's innovative approach enables healthcare professionals to conduct cardiac procedures that lead to better patient outcomes, increased procedural safety, and lower costs for the healthcare system. Through real-time tissue analysis, LUMA Vision is poised to transform how cardiac treatments are performed, ultimately benefiting both patients and healthcare providers.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics is a biotechnology company dedicated to developing innovative cell therapies that utilize hypoimmune CD8αβ induced pluripotent stem cells (iPS-T cells) to enhance cancer treatment and address other diseases. The company's advanced immune evasion technology aims to improve the effectiveness and accessibility of these therapies, ultimately reducing costs and enhancing patient outcomes. By focusing on durable responses and the potential for redosing, Shinobi Therapeutics strives to provide the healthcare industry with comprehensive immune therapies that can address a range of diseases, including cancer and genetic disorders.
Arcwood Environmental
Acquisition in 2023
Heritage Environmental Services is a privately held environmental services firm based in Indianapolis, Indiana, with over 45 years of experience in the industry. The company specializes in providing a range of environmental management and consultancy services. Its offerings include waste treatment, landfill disposal, logistics, laboratory testing, industrial maintenance, and regulatory training. Heritage is committed to assisting clients in navigating environmental challenges while ensuring compliance with regulations and promoting sustainable practices.
HRBrain
Acquisition in 2023
HRBrain, Inc. is a Tokyo-based company founded in 2016 that specializes in providing cloud-based human resource evaluation services. It operates an online platform designed to streamline the management and assessment of employee goals, offering centralized management of human resource data, personal evaluations, and organizational structure analysis. The platform enables businesses to visualize and analyze accumulated evaluation data, facilitating effective personnel evaluation and management of interview logs and target sheets. By leveraging its technology, HRBrain assists companies and HR professionals in developing strategic management measures to enhance workforce performance.
Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates engineered viral vector vaccines for cancer treatment. The company's innovative platform leverages a portfolio of modified viral vectors, specifically designed for the efficient expression of long strings of tumor neoantigens. This approach is complemented by a toolkit that facilitates the induction of robust antitumor T-cell responses, effectively enhancing cancer-specific cellular immunity in patients. Through its research and development efforts, Nouscom aims to improve cancer treatment outcomes by harnessing the body's immune system to target and combat cancer cells.
Statera Energy
Acquisition in 2023
Statera Energy is a UK-based company engaged in the development, ownership, and operation of energy infrastructure. Its portfolio comprises energy storage facilities and high-efficiency gas reciprocating engines, all developed and managed in-house from construction through operation. The company's primary objective is to enhance flexibility within the UK electricity system, supporting national grid operators, distribution network operators (DNOs), and energy wholesalers in their transition towards a low-carbon future.
MinervaX
Venture Round in 2023
MinervaX is a biotechnology company focused on developing maternal vaccines to prevent infections caused by Group B streptococcus (GBS), which can lead to serious adverse pregnancy outcomes and life-threatening conditions for newborns. The company leverages a specific fusion protein that has shown promise in eliciting protective immunity against various clinically relevant GBS strains. By concentrating on this innovative vaccine approach, MinervaX aims to provide medical professionals with effective tools to safeguard newborns from bacterial infections, ultimately enhancing maternal and infant health outcomes.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
VetPartners
Acquisition in 2023
VetPartners empowers their people to perform through education, guidance, support, simple processes and respectful relationships. They foster and create connection across their own network and the wider industry they work in. They are committed to doing what is right, being empathetic and supportive.
AstronauTx
Series A in 2023
AstronauTx is a biotechnology company focused on developing innovative treatments for Alzheimer's disease and other neurodegenerative conditions. The company specializes in restoring the normal function of astrocytes, which are crucial for supporting neuronal activity and maintaining brain health. In healthy individuals, astrocytes play a vital role in metabolism and the integrity of the blood-brain barrier; however, in neurodegenerative diseases, their dysfunction can contribute to neurotoxicity. By targeting these processes, AstronauTx aims to enable healthcare professionals to more effectively address the challenges posed by dementias, ultimately improving patient outcomes.
Wellhub is a corporate wellness platform designed to enhance employee engagement through improved physical activity. The company connects organizations with a diverse network of partners focused on fitness, emotional well-being, nutrition, and mindfulness. By offering a comprehensive subscription service, Wellhub enables employees to access various wellness options that promote lasting behavioral change and foster a healthier work environment. With over 2,000 clients, Wellhub is recognized for its ability to drive individual performance and overall business success by revolutionizing how employees engage in physical activity.
Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.
Dechra Pharmaceuticals
Acquisition in 2023
Dechra Pharmaceuticals PLC is a prominent developer and manufacturer of veterinary pharmaceuticals and related products, focusing on improving animal health and welfare. The company operates through three main segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. It provides a diverse range of products, including endocrinology, dermatology, analgesia, and anesthesia treatments for dogs and cats, as well as antibiotics and vaccines for poultry, pigs, and cattle. Additionally, Dechra offers nutrition products aimed at addressing various health conditions in pets, such as allergies and obesity. The company also distributes veterinary pharmaceuticals and equipment and provides related training and support services. Founded in 1997 and headquartered in Northwich, the United Kingdom, Dechra Pharmaceuticals markets its products through a network of wholesalers and distributors, emphasizing its commitment to enhancing animal health globally.
VarmX is a pharmaceutical spin-off from the Leiden University Medical Center, focused on the development and manufacturing of therapeutic proteins aimed at restoring blood clotting in patients experiencing bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X that can promptly reinstate blood clotting in patients using direct factor Xa anticoagulants, such as rivaroxaban, apixaban, and edoxaban. These anticoagulants, commonly prescribed for the prevention and treatment of thrombosis and stroke, often lead to severe bleeding as a side effect. PseudoXa addresses this critical issue by effectively stopping and preventing bleeding, thereby enhancing the safety of anticoagulant therapy for millions of patients worldwide.
Evommune, Inc. is a biotechnology company based in Los Altos, California, that develops and manufactures tissue-based medicines for inflammatory diseases. Incorporated in 2020, Evommune focuses on creating novel strategies to treat these disorders by addressing both symptoms and the underlying causes, thereby halting disease progression. The company employs a proprietary tissue-based platform that accelerates the discovery of innovative treatments, enhancing the potential for clinical success. With a commitment to improving the quality of life for patients, Evommune's pipeline includes initiatives aimed at tackling a range of prevalent inflammatory illnesses, positioning the company as a leader in advancing therapies in the fields of immunology and dermatology.
Noya is a company focused on combating climate change through innovative carbon capture technology. By retrofitting existing industrial cooling towers, Noya integrates a non-toxic chemical blend that efficiently captures carbon dioxide without requiring physical alterations to the equipment. This approach allows industries to reduce their carbon footprints while simultaneously generating a valuable resource, as the captured CO2 is sold to companies that utilize it as a raw material. Noya's mission is to accelerate the global transition towards a carbon-negative future, positioning itself as a key player in the development of sustainable solutions for environmental challenges.
Lazer Logistics
Acquisition in 2023
Lazer Logistics is a provider of outsourced yard management services that operates across various industries, including food and beverage, consumer packaged goods, e-commerce retail, and pulp and paper. The company specializes in yard spotting, managing the movement of loaded and empty trailers within customer facilities and offsite locations. Lazer Logistics offers a range of services, including trailer rentals, trailer shuttling, staffing for gate personnel, and computerized yard management systems. Their expertise ensures the efficient and safe movement of trailers, tailored to meet the specific needs of clients in managing their production and distribution operations.
GotPhoto
Acquisition in 2023
GotPhoto is a company that offers a software-as-a-service (SaaS) platform designed specifically for photographers, particularly those specializing in school and volume photography. By providing an efficient workflow and e-commerce solutions, GotPhoto enables photographers to sell their photos online seamlessly. The platform simplifies the process of managing photo sales, allowing photographers to focus on their creative work while effectively reaching their customers. With its user-friendly interface and tailored features, GotPhoto positions itself as a key player in the photography industry, facilitating online transactions and enhancing the overall experience for both photographers and their clients.
Tion Renewables
Acquisition in 2023
Tion Renewables is a company engaged in the production of alternative energy, specializing in the development and management of a diverse portfolio of renewable energy plants. It operates wind and solar farms across Europe, contributing to the generation of cleaner energy. By focusing on onshore wind and photovoltaic power plants, Tion Renewables supports clients in their transition toward sustainable energy solutions, aligning with global efforts to enhance the use of renewable resources. The company's initiatives reflect a commitment to promoting a greener future through its strategic investment in renewable energy infrastructure.
IntegrityNext
Venture Round in 2023
IntegrityNext is a Munich-based company founded in 2016 by Martin Berr-Sorokin that specializes in supply chain compliance and sustainability monitoring. The company offers a cloud-based platform that enables businesses to oversee their suppliers' compliance with regulatory requirements, thereby reducing risk. Its platform automates the collection of supplier self-assessments and certificates, while also monitoring social media for potential malpractice and reputational threats. With features such as automated risk alerts, a pre-built supplier questionnaire, and a real-time dashboard, IntegrityNext assists small and medium-sized enterprises in translating complex compliance data requirements from international regulations into effective processes and systems. This comprehensive approach to supply chain compliance supports organizations in achieving greater transparency and accountability in their operations.
QurAlis Corporation is a clinical-stage biotechnology company focused on discovering and developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Established in 2016 and based in Cambridge, Massachusetts, QurAlis employs proprietary platforms and biomarkers to create precision medicines that target genetically validated disease-causing alterations. The company’s pipeline includes innovative treatments aimed at specific subtypes of ALS, such as therapies that restore dysfunctional cellular waste clearance, manage overactive neurons, and eliminate toxic proteins. Through its advanced antisense oligonucleotides and small molecule programs, QurAlis seeks to halt disease progression and significantly improve patient outcomes for those affected by ALS.
SK Shielders
Acquisition in 2023
SK Shielders, operating under ADT Caps Co. Ltd., is a prominent security service provider in South Korea, established in 1971 and headquartered in Seoul. The company specializes in machine security, personnel guarding, security monitoring, and dispatch services, catering to a diverse clientele that includes households, commercial establishments like restaurants and offices, and various business sectors. With a subscriber base of 570,000, SK Shielders stands as the second-largest security firm in the country, following Samsung's S-One. In addition to traditional security services, the company also offers building maintenance and fire prevention solutions, reinforcing its comprehensive approach to safety and security.
Radius Global Infrastructure
Acquisition in 2023
Radius Global Infrastructure, Inc., headquartered in New York, specializes in the ownership and leasing of essential communications properties for wireless carriers and tower companies. Through its subsidiary, AP Wireless, the company manages a portfolio of ground, rooftop, and other critical sites that support the infrastructure necessary for cell site antenna systems. As of mid-2020, Radius held interests in approximately 6,600 leases across about 5,000 communication sites in the United States and 18 additional countries. Recognized as a significant international aggregator of rental streams in the wireless communications sector, Radius Global Infrastructure focuses on acquiring and managing telecom real property interests, which provides its clients with opportunities to expand into adjacent digital infrastructure markets.
Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.
va-Q-tec
Acquisition in 2023
va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.
Cardiac Dimensions
Series D in 2023
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.
Saur SAS
Acquisition in 2023
Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.
Ontinue
Acquisition in 2023
Ontinue is a developer of a security operations platform that specializes in AI-powered Managed Extended Detection and Response (MXDR) services. The company's platform harnesses artificial intelligence to enhance security by localizing incidents, streamlining communication, and delivering prevention services. This approach enables clients to improve operational efficiency and advance the maturity of their security programs, ultimately providing a comprehensive solution to modern cybersecurity challenges.
Madison Energy Infrastructure
Acquisition in 2022
Madison Energy Infrastructure is a platform that creates, owns, and manages renewable energy projects.
Cirba Solutions
Private Equity Round in 2022
Cirba Solutions specializes in battery recycling services, catering to corporations, governments, municipalities, and households. The company collects end-of-life batteries and processes them to extract critical materials, which are then reintroduced into the supply chain using a circular economy model. This approach minimizes waste and promotes environmental compliance through advanced technological processes. Cirba Solutions offers comprehensive services including battery inventory management, de-installation, project management, recycling systems, and accessories for damaged batteries. These solutions help clients meet regulatory requirements and divert waste from landfills while ensuring the safe recycling of each component.
SHL Medical
Secondary Market in 2022
SHL Medical AG specializes in the design, development, and manufacturing of advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989 and headquartered in Zug, Switzerland, the company serves pharmaceutical and biotech firms around the globe. In addition to its core product offerings, SHL Medical provides comprehensive services such as final assembly, labeling, and packaging. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring that it delivers innovative and reliable solutions tailored to meet the needs of its clients.
Trescal
Acquisition in 2022
Trescal specializes in calibration and asset management services, offering a range of multi-brand solutions across various metrological domains. The company operates independently from original equipment manufacturers (OEMs), providing clients with calibration services that are designed to improve industrial performance. Trescal’s services are available both on-site and in dedicated laboratories, ensuring compliance with International Organization for Standardization (ISO) standards. By focusing on enhancing measurement processes, Trescal supports clients in achieving greater accuracy and efficiency in their operations.
Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.
Billtrust
Acquisition in 2022
Billtrust is a provider of cloud-based software that specializes in streamlining and automating accounts receivable (AR) processes for B2B commerce. The company addresses the inefficiencies of traditional AR methods, which often rely on outdated, manual, and paper-based practices. By offering a comprehensive order-to-cash platform, Billtrust facilitates the entire process from order receipt to payment collection, thereby enhancing revenue capture and cash flow for its clients. Its solutions encompass various functions, including credit decisioning, online ordering, invoicing, cash application, and collections. Billtrust integrates with multiple ecosystem players, such as financial institutions and enterprise resource planning systems, enabling customers to transition from costly paper invoicing to efficient electronic billing and payment methods. This transformation not only accelerates payment processing but also generates significant cost savings and improves the overall user experience.
etherna immunotherapies
Series B in 2022
eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.
FundamentalVR
Series B in 2022
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.
United Talent Agency
Secondary Market in 2022
United Talent Agency (UTA) is a talent and entertainment agency that represents actors, writers, directors, recording artists, and corporate brands across various industries such as film, television, music, digital media, and more. With a roster of high-profile clients including Johnny Depp, Harrison Ford, Jennifer Lopez, and many others, UTA specializes in providing representation for individuals and companies in the entertainment industry. In addition to talent representation, UTA also works with emerging technology companies and offers services in intellectual property, computer and video games, commercials, voiceovers, endorsements, and entertainment marketing.
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
SPT Labtech
Acquisition in 2022
SPT Labtech is a manufacturer and designer of automated instrumentation and consumables for life science research. The company specializes in enhancing agility, efficiency, and productivity across various applications, including drug discovery, structural biology, molecular biology, and genomics. Its product portfolio focuses on minimizing assay volumes, streamlining workflows, and reducing material handling costs, thereby empowering life scientists to accelerate their research. SPT Labtech emphasizes collaboration and deep application knowledge, which informs its research and development efforts. The company is committed to addressing existing customer challenges through innovative solutions, driven by a strong ethos of customer-centricity. Additionally, its extensive expertise allows SPT Labtech to manage the entire life cycle of its products, from initial design and engineering to final manufacture and support, ensuring high-quality technical assistance and fostering strong client relationships.
ImCheck Therapeutics
Series C in 2022
ImCheck Therapeutics is a biopharmaceutical company based in Marseille, France, that specializes in developing immunotherapeutics aimed at addressing severe unmet medical needs, particularly in the field of immuno-oncology. Founded in 2015, the company focuses on designing and developing immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules. These innovative therapies engage γ9δ2 T cells, a specific type of immune cell, to effectively treat various cancers, including breast, gastric, and ovarian cancers, as well as other solid tumors. Through its advanced research and development efforts, ImCheck Therapeutics seeks to provide next-generation immunotherapeutics for patients suffering from immune-related diseases.
Ariceum Therapeutics
Series A in 2022
Ariceum Therapeutics is a clinical-stage radiopharmaceutical company that focuses on the detection and targeted treatment of aggressive cancers, particularly neuroendocrine tumors and other challenging malignancies. The company's lead product, 177Lu-satoreotide tetraxetan (Satoreotide), acts as an antagonist of the somatostatin type 2 receptor (SSTR2), which is commonly overexpressed in many neuroendocrine tumors. Ariceum is developing Satoreotide as a theranostic pair, which allows for both the diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, certain aggressive tumors, and childhood cancers. This approach aims to provide treatment options for conditions that currently have limited therapies and poor prognoses, enabling healthcare professionals to deliver more effective treatments with reduced side effects.
Envirotainer
Acquisition in 2022
Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company has built a reputation as a global leader in secure cold chain solutions for the pharmaceutical industry. Envirotainer provides a range of services, including laboratory testing, qualification and validation support, data collection, and training through its Qualified Envirotainer Program. The company's extensive network includes operations centers in key locations such as Singapore, Dallas, Frankfurt, and Toronto, as well as a station in Hyderabad, India. By leveraging its innovative container solutions and global presence, Envirotainer meets the critical needs of pharmaceutical and biotech clients for reliable shipping solutions that maintain the integrity of temperature-sensitive products.
Redwood Capital Group
Acquisition in 2022
Redwood Capital Group, LLC leverages over 75 years of combined experience in the commercial real estate industry, targeting the acquisition and management of multi-family real estate. Its management team has handled in excess of eight billion dollars of commercial real estate investment, the lion’s share of which has been in multi-family assets. Our mission is to be the foremost choice for institutional and private equity in pursuit of strategic, multi-family investment. We deliver exceptional results to our investors and are uncompromising in our execution of strategy.
Guardian
Acquisition in 2022
Guardian is the local Chinese pest control operator, with a strong presence in Eastern and Southern China.
BPEA EQT
Acquisition in 2022
BPEA EQT is a prominent private alternative investment firm headquartered in Hong Kong, with a substantial commitment of over USD 20 billion in capital. Established in 1997, the firm specializes in private equity investments, focusing on buyouts and providing growth capital to companies, particularly within the Asia Pacific region, while also seeking global opportunities that can leverage expansion into this market. BPEA EQT manages dedicated funds in private real estate and private credit, reflecting its diverse investment strategy. With a workforce of over 180 employees across offices in key countries including China, India, Japan, Australia, and Singapore, the firm oversees approximately 43 active portfolio companies in Asia, collectively employing over 224,000 individuals and generating sales of around USD 39 billion.
Ardoq AS, established in 2013 and headquartered in Oslo, Norway, with offices in New York, London, and Copenhagen, specializes in developing solutions to document and visualize complex computer systems. Its flagship product, Ardoq, combines textual documentation with interactive visualizations, offering features such as automatic visualization generation, real-time collaboration, and model-based documentation. Ardoq serves a wide range of professionals, including business users, developers, project managers, and stakeholders, empowering them to understand interdependencies, plan changes, and make data-driven decisions. The platform enables the entire organization to contribute to documentation, fostering a collaborative environment for digital transformation.
LSP is a defense and space company that specializes in providing strategy consulting services. The firm focuses on delivering expert guidance and insights to clients in the defense and aerospace sectors, helping them navigate complex challenges and develop effective strategies. Through its consulting services, LSP aims to enhance the operational efficiency and strategic positioning of its clients within the highly specialized defense and space industries.